Holdings of Diversified Healthcare Trust (DHC) are aligned with the stars

With 0.67 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.47 shares. During the session, the REIT – Healthcare Facilities company that operates in wider Real Estate sector, reached to the highest price of $2.7600 whereas the lowest price it dropped to was $2.6300. The 52-week range on DHC shows that it touched its highest point at $3.96 and its lowest point at $0.64 during that stretch. It currently has a 1-year price target of $4.50. With its current market cap of 649.22 million, DHC has annualized dividend of $0.04 (1.48%) while the current yield stands at 0.04 (1.48%). Beta for the stock currently stands at 2.04.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DHC was down-trending over the past week, with a drop of -1.82%, but this was down by -11.18% over a month. Three-month performance surged to 31.71% while six-month performance fell -12.05%. The stock gained 286.60% in the past year, while it has lost -27.81% so far this year. A look at the trailing 12-month EPS for DHC yields -1.07 with Next year EPS estimates of -1.05. For the next quarter, that number is -0.25. This implies an EPS growth rate of 12.60% for this year and 0.00% for next year.

Float and Shares Shorts:

At present, 239.69 million DHC shares are outstanding with a float of 215.81 million shares on hand for trading. On Jan 31, 2024, short shares totaled 4.57 million, which was 1.90% higher than short shares on Dec 29, 2023. In addition to Mr. Adam David Portnoy as the firm’s Managing Chair of the Board, Mr. Christopher J. Bilotto serves as its President & CEO.


Institutional Ownership:

Through their ownership of 73.46% of DHC’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for DHC since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With DHC analysts setting a high price target of $4.50 and a low target of $4.50, the average target price over the next 12 months is $4.50. Based on these targets, DHC could surge 66.67% to reach the target high and rise by 66.67% to reach the target low. Reaching the average price target will result in a growth of 66.67% from current levels.


Dividends & Yield:

In terms of dividends, DHC has a current ratio of $0.04, which is $0.04 over the trailing 12-months, while a dividend of $0.33 is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and DHC currently yields $1.48. In the past year, DHC’s dividend yield has been $1.48, but when looking at the stock over the past five years, its yield has been $5.75. Accordingly, DHC has a current buyback yield of $0.06. This was $0.06 for the TTM, and it was $0.04 for the past five years.

Summary of Insider Activity:

Insiders traded DHC stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 11 while that of sell transactions has risen to 3 over the past year. The total number of shares bought during that period was 2,240,000 while 42,925 shares were sold.